PharmEasy-parent API Holdings reported a net loss of ₹3,992 crore in the financial year 2022, as compared to ₹641 crore in the financial year 2021, filings showed. Its total revenue rose to ₹5,729 crore from ₹2,335 crore a year earlier. Its operating revenue stood at ₹5,781 crore. The firm is backed by Temasek and Nandan Nilekani's Fundamentum Partnership among others.